Lioresal Intrathecal

Indicated For

severe spasticity

About This Medication

# Amneal Patient Assistance Program Patient Guide: How to Get Lioresal Intrathecal (baclofen) at Low or No Cost Lioresal Intrathecal (baclofen) is a prescription medication delivered directly into the spinal fluid via an implanted pump to treat severe muscle spasms and spasticity caused by conditions like multiple sclerosis, spinal cord injuries, or cerebral palsy. The **Amneal Patient Assistance Program (PAP)** from Amneal Pharmaceuticals offers eligible patients free medication for up to one year, shipped directly to your home, helping those facing financial hardship get this important treatment without high costs[1][2]. ## Who Qualifies for the Program? This program is designed for **uninsured, underinsured, or financially strained patients** who are U.S. residents (including Puerto Rico and U.S. Virgin Islands). You must lack affordable prescription coverage and meet household income requirements, which are detailed in the application—specific dollar thresholds aren't publicly listed but require financial documentation to verify[2]. If you're on Medicare Part D, you need to have spent at least **3% of your annual household income** out-of-pocket on prescriptions that year, proven by an Explanation of Benefits (EOB) or pharmacy printout[2][5][9]. The program prioritizes those who can't otherwise afford their Amneal medications, like Lioresal Intrathecal. It's not for patients with state or federally funded coverage that fully covers the drug. Always check the latest application for exact criteria, as they can update[1][2]. ## About Lioresal Intrathecal (baclofen) **Lioresal Intrathecal** is baclofen in injectable form for intrathecal use—meaning it's administered via a pump implanted under the skin that delivers the drug precisely to the spinal canal. This targeted approach effectively relaxes stiff, spastic muscles that don't respond well to oral medications, improving mobility, reducing pain, and enhancing quality of life for patients with severe spasticity[1]. Common uses include managing spasticity from spinal cord trauma, multiple sclerosis, or stroke. It's refilled periodically by healthcare providers. Side effects can include drowsiness, weakness, or pump-related issues, so work closely with your doctor. This PAP ensures access to Amneal's version without cost barriers for qualifiers[1][2]. ## Income Eligibility Breakdown Exact income limits (e.g., Federal Poverty Level percentages) aren't specified online; eligibility is determined case-by-case via your application and supporting documents like tax returns, pay stubs, or W-2s[2]. Medicare Part D patients have the added 3% spend requirement. Here's a simple table summarizing key financial factors: | Category | Details | |----------|---------| | **Household Income** | Must meet program thresholds (submit proof for review)[2] | | **Medicare Part D** | Spent ≥3% of household income on Rx drugs YTD (EOB or pharmacy printout required)[2][5] | | **Documentation** | Pay stubs, tax returns, bank statements—full list in app[2] | | **Residency** | U.S., PR, USVI only[2] | | **Insurance** | No affordable coverage; excludes full govt. programs[2][5] | Contact the program at (877) 764-9021 for personalized guidance on your situation[2]. ## Insurance Requirements The program is for patients **without affordable insurance coverage** for the prescription. Provide full details in Section 2 of the application. **Medicare Part D** enrollees qualify only with proof of significant out-of-pocket spend (≥3% household income)[2][5][9]. It excludes those submitting claims under Medicare, Medicaid, or similar federal/state programs[5]. Uninsured or underinsured patients facing hardship are ideal candidates—your doctor can help clarify[1][2]. ## Step-by-Step Application Process Applying is straightforward but requires teamwork with your healthcare provider. Multiple methods are available: phone, fax, or mail[2]. 1. **Discuss with Your Doctor**: Share this guide. They complete practitioner sections, attach an **original signed prescription**, and provide their contact/DEA/State License[2][5]. 2. **Download or Request Form**: Get the application from amneal.com/support or call (877) 764-9021[1][2]. 3. **Patient Completes Sections**: - Section 1: Personal info (name, address, DOB, phone)[2]. - Section 2: All insurance details[2]. - Section 3: Income/financial info + signature[2]. - Medicare Part D: Attach EOB or pharmacy YTD spend proof[2]. 4. **Gather Documents**: - Proof of income (e.g., recent pay stubs, 1040 tax form)[2]. - Original prescription[2]. - Spend proof if applicable[2]. 5. **Submit**: Fax/mail to Amneal PAP, PO Box 220586, Charlotte, NC 28222; Phone: (877) 764-9021; Fax: (877) 764-9022[2]. Your doctor/practitioner must sign off. Approval grants up to **one year of free meds**, shipped home[1][2]. ## Timeline and Delivery Processing time isn't specified but expect review soon after submission—call for status updates[2]. If approved, medication ships directly to your **home address** provided[1][2][9]. **Reauthorization is required** annually; Amneal mails a renewal form before expiration[2][5]. Stay proactive to avoid gaps. ## Alternatives if Denied or Ineligible - **Appeal**: Call (877) 764-9021 to discuss reasons and resubmit with more docs[2]. - **Other Programs**: Check PAN Foundation, NeedyMeds, or RxAssist for baclofen aid. - **Generic Options**: Ask your doctor about alternatives; no biosimilars listed[2]. - **Manufacturer Support**: Explore Amneal PATHways for copay help if insured (866-426-6325)[3][8]. - **State Programs**: Medicaid, 340B clinics, or patient advocacy groups. ## Important Disclaimer This guide is for informational purposes based on available sources as of 2026 and is not medical/financial advice. Program rules can change—verify with Amneal at (877) 764-9021 or amneal.com. Eligibility isn't guaranteed; consult your doctor. Amneal may discontinue enrollment without notice. Free meds don't replace insurance obligations[1][2][5]. (Word count: 1028)

Program information last verified: March 30, 2026